Latest AI and machine learning research in oncology/hematology for healthcare professionals.
Kidney abnormality segmentation has important potential to enhance the clinical workflow, especially in settings requiring quantitative assessments. Kidney volume could serve as an important biomarker for renal diseases, with changes in volume correlating directly with kidney function. Currently, clinical practice often relies on subjective visual assessment for evaluating kidney size and abnorm...
OBJECTIVE: To develop a novel MRI-based deep learning (DL) diagnostic model, utilizing multicenter large-sample data, for the preoperative differentiation of sinonasal inverted papilloma (SIP) from SIP-transformed squamous cell carcinoma (SIP-SCC).
The purpose of this study was to investigate the utility of deep learning image reconstruction at medium and high intensity levels (DLIR-M and DLIR-H,...
BACKGROUND: The pathological assessment of International Society of Urological Pathology (ISUP) nuclear grading is crucial for the management of clear...
BACKGROUND: Advances in cancer detection and treatment have significantly improved survival rates and led to an increasing prevalence of the second pr...
INTRODUCTION: Breast cancer is the most common malignant disease in the female population and one of the most common diseases in developed countries. ...
BACKGROUND: Achieving long-term clinical remission in Crohn's disease (CD) with antitumor necrosis factor α (anti-TNF-α) agents remains challenging.
Colorectal liver metastasis (CRLM) is a primary factor contributing to poor prognosis and metastasis in colorectal cancer (CRC) patients. This study a...
OBJECTIVE: To explore the bioinformatics characteristics and potential mechanisms of signal transducer and activator of transcription (STAT3) in chron...
The growing burden of cancer and recent surge in healthcare data availability call for new ways of analysing this multifactorial disease and improving...
BACKGROUND: CD8T cells, also known as cytotoxic T lymphocytes, play a key role in the tumor immune microenvironment (TME) and immune response. The aim...
Combination therapies are one potential approach to improve the outcomes of patients with refractory or relapsed disease. However, comprehensive testi...
High-grade serous ovarian cancer (HGSOC) is the most common and aggressive subtype of epithelial ovarian cancer, often diagnosed at advanced stages wi...
Pancreatic cystic neoplasms (PCNs) are a complex group of lesions with a spectrum of malignancy. Accurate differentiation of PCN types is crucial for ...
BACKGROUND: Patients with gastroenteropancreatic neuroendocrine neoplasms (GEP-NENs) and liver metastases typically exhibit poor prognoses. However, a...
BACKGROUND: One of the most common and prevalent cancers is laryngeal squamous cell carcinoma (LSCC), which poses a great threat to the life and healt...
BACKGROUND: Lung cancer (LC) remains the leading cause of cancer-related mortality worldwide. Early detection through targeted screening significantly...
INTRODUCTION: Artificial Intelligence (AI) is playing an increasing role in advancing diagnostic processes and decision-making in healthcare. In the e...
Although immunotherapy demonstrates considerable prospect in overcoming solid tumors, its clinical efficacy is limited by several factors, such as poo...
Primary Central Nervous System Lymphoma is an aggressive central nervous system neoplasm with poor response to pharmacological treatment, partially du...